Navigation Links
BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman
Date:10/20/2009

SAN DIEGO, Oct. 20 /PRNewswire/ -- BrainCells Inc., a company leading the scientific research of neurogenesis using its proprietary neural stem cell platform technology to identify novel pathways for the treatment of central nervous system (CNS) diseases, announced the appointment of Drs. Edward Scolnick from the Broad Institute of MIT and Harvard and David Holtzman of Washington University School of Medicine to its scientific advisory board. The appointees join BrainCells' advisory boards comprised of world-class scientists of neurogenesis and CNS disease. Existing board members represent The Salk Institute, Columbia University, Stanford University, Cedars-Sinai Medical Center and Massachusetts General Hospital.

"Ed and David are two highly esteemed and accomplished neuroscientists; a great honor for the company and a validation of our research in neurogenesis," said Jim Schoeneck, chief executive officer of BrainCells Inc. "Their backgrounds in research and drug development will be invaluable as we prioritize clinical applications for our assets. In the past five years, we've screened more than 1,000 compounds against 150 novel and known mechanisms, moved neurogenic compounds into Phase 2 clinical trials and identified several preclinical candidates."

Dr. Edward Scolnick is an internationally recognized thought leader in neuroscience research. He currently serves as director of the Psychiatric Disease Program and the Stanley Center for Psychiatric Research at the Broad Institute, focused on identifying risk genes for bipolar disorder and schizophrenia. Prior to joining the Broad Institute, Dr. Scolnick spent more than 20 years with Merck in various positions including president of Merck Research Laboratories. He has also worked at the National Cancer Institute and National Heart Association. Dr. Scolnick is a member of National Academy of Sciences, the American Academy of Arts and Sciences and the Institute of Medicine. He served on
'/>"/>

SOURCE BrainCells Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BrainCells Inc. Initiates Phase 2 Clinical Trial with BCI-540 for Depression with Anxiety
2. Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression
3. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
4. Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors
5. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
6. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
7. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
8. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
9. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
10. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
11. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... LEHIGH VALLEY, Pa. , July 28, 2014 /PRNewswire/ ... a reliable, uninterrupted supply of medical oxygen is vital ... company to technical innovations that not only improve the ... gas use. Air Products will highlight these systems—including systems ... systems that reduce oxygen loss—from August 4-5 at the ...
(Date:7/28/2014)... 28, 2014  Array BioPharma Inc. (Nasdaq:   ... fourth quarter and full year of fiscal ... discuss those results on Tuesday, August 12, ... Michael Carruthers , Chief Financial Officer ... 12, 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) 619-6397Pass ...
(Date:7/28/2014)... -- Houston dentist , Dr. Behzad Nazari ... Invisalign. With access to this increasingly popular orthodontic ... without feeling self-conscious in the process. Invisalign offers ... of braces, but patients who choose Invisalign over ... support for their oral health and comfort during ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2
... Reportlinker.com announces that a new market research ... The Outlook for Medical ... http://www.reportlinker.com/p0192649/The-Outlook-for-Medical-Devices-in-South-East-Asia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Managed_care ... the Middle East is published by Espicom ...
... Belt Technologies, Inc., a medical device company focused ... providing precise robotic control for use initially in ... including neurosurgery, spinal and otolaryngology ("NET"), announced today ... partial knee replacements will be featured at the ...
Cached Medicine Technology:The Outlook for Medical Devices in South East Asia 2The Outlook for Medical Devices in South East Asia 3The Outlook for Medical Devices in South East Asia 4The Outlook for Medical Devices in South East Asia 5Blue Belt Technologies to Showcase Navio™ PFS System at CAOS UK 2012 Conference in Glasgow, UK 2
(Date:7/28/2014)... St. Jude Children’s Research Hospital ... of Defense Employer Support Freedom Award from the Employer Support ... Defense. The award is the highest honor given by the ... who serve in the National Guard and Reserve. , “We ... their contributions to the St. Jude mission and to our ...
(Date:7/28/2014)... possible by a test developed at University of Colorado ... of Pharmacy), AURORA, Colo (July 28, 2014) An influential ... Pharmacology Laboratory at the CU School of Pharmacy, helps ... Truvada (a combination of tenofovir/emtricitabine), which is taken once ... presented during the AIDS 2014 Conference and published in ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The ... Lipase), Applications (Food & Beverages, Cleaning Agents, Bio-Fuel, ... Forecasts to 2018” defines and segments the global ... the global value for industrial enzymes. It also ... industrial enzymes market with analysis of trends, opportunities, ...
(Date:7/28/2014)... 2014 Qualis Health, one of ... organizations, has published a complimentary, online toolkit that ... patients and families in infection control. Tested ... the toolkit provides a step-by-step roadmap for implementing ... their families early in a hospital stay. , ...
(Date:7/28/2014)... Dennis Thompson HealthDay ... -- Babies born prematurely appear to have a slightly ... will carry into adulthood, Swedish researchers report. Doctors ... weeks, gestation have a raised risk of deep vein ... blood clotting in the veins, the researchers noted in ...
Breaking Medicine News(10 mins):Health News:St. Jude Children’s Research Hospital Receives Secretary of Defense Employer Support Freedom Award 2Health News:St. Jude Children’s Research Hospital Receives Secretary of Defense Employer Support Freedom Award 3Health News:HIV research findings made possible by a test developed at CU School of Pharmacy 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 4Health News:Patient Engagement in Hospital Infection Control: Online Toolkit Provides a New Solution 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3
... a team of researchers an expression pattern of certain ... in lunch cancer patients.// ,The analysis of these ... of diagnostic and prognostic tools for lung cancer. ... Ohio; the Jikei University School of Medicine, Tokyo, Japan; ...
... for the final hearing of India's biggest ever medical compensation ... in a woman's death eight years ago.// ,"I ... again be postponed by the machinations of my opponents," Ohio-based ... of the final hearing at the National Consumer Disputes Redressal ...
... Welfare has said that measures taken to check the ... sums in public health expenditure. // Preventive Health Initiatives ... to statistics, these spending are just $68 a year ... $77 million was expended on public health programs in ...
... rendered to Scotland children, could soon come to an end, ... by ministers. // Dental practices in Scotland yield a considerable ... of registered NHS patients. ,There exists a flaw ... extra payments, says the British Dental Association (BDA). This could ...
... Health Service has conducted a study and found that the rates ... , More parents are getting their children immunized with the ... below the Scottish Executive's target level of 95% by the age ... of immunization. The drop was due to the vaccines association with ...
... soon be launched for commercial use in Hungary following ... Minister, Ferenc Gyurcsany, made the announcement. ,Hungary ... year. Vaccine trials conducted on animal and human models ... claimed to confer protection against the H5N1 virus that ...
Cached Medicine News:Health News:Lung cancer molecular profile discovered by researchers. 2Health News:Stage Set For Final Hearing On India’s Biggest Ever Medical Compensation Clai 2Health News:Children In Scotland Denied Access To Dental Care 2